Squarepoint’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Squarepoint’s Portfolio EDVA Stock Details EDVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-140	Closed	-$3.6K	–	5305
2024 Q4	$3.6K	Buy	+140	New	+$4.64K	﹤0.01%	4964

Other funds holding EDVA

Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Squarepoint's EDVA Position: Q1 2025 in Review

Squarepoint sold out of Endovia Health Sciences, Inc. (EDVA) in Q1 2025, closing a stake of 140 shares — an estimated $3.6K sold.

Squarepoint first reported a position in EDVA in Q4 2024 and held it in 1 quarter. The position peaked at $3.6K in Q4 2024. 11 funds tracked by Wall St. Rank hold EDVA as of Q1 2025.

Squarepoint reported no remaining Endovia Health Sciences, Inc. position as of Q1 2025 after selling out during the quarter.
Squarepoint sold 140 Endovia Health Sciences, Inc. shares in Q1 2025, an estimated $3.6K.
Squarepoint first reported a position in Endovia Health Sciences, Inc. in Q4 2024 and held it in 1 quarter.
Squarepoint's Endovia Health Sciences, Inc. position peaked at $3.6K in Q4 2024.
11 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q1 2025.

Based on Squarepoint's 13F filing for Q1 2025, filed 15 May 2025.